Current status of hematopoietic stem cell transplantation in the treatment of aplastic anemia
10.3969/j.issn.2095-4344.2073
- Author:
Yuan Feng WEI
1
Author Information
1. Department of Hematopathology, Yijishan Hospital of Wannan Medical College
- Publication Type:Journal Article
- Keywords:
Aplastic anemia;
Cord blood transplantation;
Haploidentical hematopoietic stem cell transplantation;
Hematopoietic stem cell transplantation;
HLA-matched sibling donor;
Unrelated donor
- From:
Chinese Journal of Tissue Engineering Research
2020;24(19):3093-3100
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND: A great progress has been achieved in the allogeneic hematopoietic stem cell transplantation for aplastic anemia. However, graft-versus-host disease and graft failure after transplantation are still the main causes of non-relapse death, which seriously affect the survival of patients. OBJECTIVE: To summarize the current status and progress of allogeneic hematopoietic cell transplantation in the treatment of aplastic anemia. METHODS: The first author retrieved PubMed, CNKI, WanFang and VIP databases for the articles concerning allogeneic hematopoietic stem cell transplantation for aplastic anemia published from January 1990 to September 2019. The keywords were “aplastic anemia, matched sibling donor hematopoietic stem cell transplantation, unrelated donor hematopoietic stem cell transplantation, haploidentical hematopoietic stem cell transplantation, cord blood transplantation” in Chinese and English, respectively. Finally 55 eligible articles were included for result analysis. RESULTS AND CONCLUSION: HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation is the first choice. Unrelated donor hematopoietic stem cell transplantation may be an effective and feasible first-line therapy in pediatric severe aplastic anemia patients with no matched sibling donors. Haploidentical hematopoietic stem cell transplantation and cord blood transplantation can also be important transplantation methods for severe aplastic anemia when lack of HLA-matched donors.
